These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17873458)

  • 21. Chemoradiation in pancreatic adenocarcinoma: a literature review.
    Roy R; Maraveyas A
    Oncologist; 2010; 15(3):259-69. PubMed ID: 20203172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development and controversies of adjuvant therapy for pancreatic cancer.
    Lau WY; Lai EC
    Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):121-5. PubMed ID: 18397844
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant therapy for pancreatic cancer: current status, future directions.
    Regine WF; Abrams RA
    Semin Oncol; 2006 Dec; 33(6 Suppl 11):S10-3. PubMed ID: 17178279
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiochemotherapy in the management of pancreatic cancer--part II: use in adjuvant and locally unresectable settings.
    Dickler A; Abrams RA
    Semin Radiat Oncol; 2005 Oct; 15(4):235-44. PubMed ID: 16183477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Systemic and adjuvant therapy for patients with pancreatic carcinoma.
    Clark JW; Glicksman AS; Wanebo HJ
    Cancer; 1996 Aug; 78(3 Suppl):688-93. PubMed ID: 8681308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Current state and possibilities of radiotherapy in the inter- disciplinary treatment of malignancies of the stomach, pancreas and biliary tract. II. Pancreatic cancer].
    Köster R; Scherer E
    Strahlentherapie; 1984 May; 160(5):271-82. PubMed ID: 6729861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatic cancer: progress in cancer therapy.
    Pierantoni C; Pagliacci A; Scartozzi M; Berardi R; Bianconi M; Cascinu S
    Crit Rev Oncol Hematol; 2008 Jul; 67(1):27-38. PubMed ID: 18356073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of pancreatic adenocarcinoma: a European perspective.
    Gouma DJ; Busch OR; van Gulik TM
    Surg Oncol Clin N Am; 2008 Jul; 17(3):569-86, ix. PubMed ID: 18486884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current status of chemotherapy in metastatic pancreatic cancer.
    Wils JA
    Anticancer Res; 1989; 9(4):1027-31. PubMed ID: 2683988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Postoperative adjuvant treatment for pancreatic cancer: present status and future perspective].
    Uesaka K; Kanemoto H; Sugiura T; Mizuno T; Okamura Y; Kinugasa Y; Bando E; Terashima M
    Gan To Kagaku Ryoho; 2011 Sep; 38(9):1403-5. PubMed ID: 21918335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Radiotherapeutic strategies in the multimodal therapy of resectable and nonresectable pancreatic carcinoma].
    Wiegel T; Runkel N; Frommhold H; Rübe C; Hinkelbein W
    Strahlenther Onkol; 2000 Jul; 176(7):299-306. PubMed ID: 10962995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postresection chemotherapy for pancreatic cancer.
    Smaglo BG; Pishvaian MJ
    Cancer J; 2012; 18(6):614-23. PubMed ID: 23187850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoradioimmunotherapy with 5-fluorouracil, cisplatin and interferon-alpha in pancreatic and periampullary cancer: results of a feasibility study.
    Nitsche M; Horstmann O; Christiansen H; Hermann RM; Hess CF; Becker H; Pradier O; Schmidberger H
    Cancer Radiother; 2008 Dec; 12(8):817-21. PubMed ID: 18996727
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical study of the month. Adjuvant radio-chemotherapy and chemotherapy following curative resection of pancreatic cancer: results of the randomized trial ESPAC-1].
    Polus M; Jerusalem G; Sautois B; Silvestre RM; Collette MY; Closon MT; Fillet G
    Rev Med Liege; 2002 Feb; 57(2):119-22. PubMed ID: 11942178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adjuvant therapy for pancreatic cancer: a review.
    Zuckerman DS; Ryan DP
    Cancer; 2008 Jan; 112(2):243-9. PubMed ID: 18050292
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multidisciplinary management of resectable adenocarcinoma of the pancreatic head.
    Yamamoto M; Imagawa DK; Katz MH
    Expert Rev Anticancer Ther; 2008 Oct; 8(10):1611-21. PubMed ID: 18925853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pancreatic cancer: from molecular signature to target therapy.
    Longo R; Cacciamani F; Naso G; Gasparini G
    Crit Rev Oncol Hematol; 2008 Dec; 68(3):197-211. PubMed ID: 18436450
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adjuvant therapy following surgery for periampullary and pancreatic cancers.
    Sonkar AA; Poston GJ
    Eur J Surg Oncol; 2004 Nov; 30(9):911-2. PubMed ID: 15498632
    [No Abstract]   [Full Text] [Related]  

  • 39. Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy?
    Aloia TA; Lee JE; Vauthey JN; Abdalla EK; Wolff RA; Varadhachary GR; Abbruzzese JL; Crane CH; Evans DB; Pisters PW
    J Am Coll Surg; 2007 Mar; 204(3):347-55. PubMed ID: 17324767
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative chemoradiotherapy for localized pancreatic carcinoma. A perspective.
    Hoffman JP; O'Dwyer P; Agarwal P; Salazar H; Ahmad N
    Cancer; 1996 Aug; 78(3 Suppl):592-7. PubMed ID: 8681297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.